Harvard Business Review

OCTOBER 29, 2012

The nay-sayers, on the other hand, can cite the passionately defended view of the pharmaceutical industry that the cost of discovering innovative disease-curing molecules has been rising crazily — the basis for perennial campaigns for stronger intellectual property rights to safeguard pharma investments.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Leadership development Leadership transitions Managing people'

Middle Management 8

Middle Management Management Automotive Pharmaceuticals 8

Harvard Business Review

JUNE 3, 2013

Where was its leadership bench? Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? Why are so many companies struggling with a crisis of their leadership bench? food, beverage & tobacco, household and personal products); Energy & Utilities (e.g.,

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare.

COO 11

COO Sample Telecommunications Automotive 11

Harvard Business Review

SEPTEMBER 15, 2014

As Linda Hill and her colleagues have described, the company needed expert knowledge as it navigated the technically and ethically challenging waters of pharmaceutical development and marketing. The more responsible participants feel, the more energy and drive they’ll offer — and the better they’ll feel about participating.

Gilbert 9

Gilbert Participative Cooper Network Economy 9

Harvard Business Review

JUNE 16, 2016

To understand the nature of the problem, let’s look at how penicillin was brought to market. The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. In battery research, for example, scientists have long focused on finding materials with greater energy density.

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

OCTOBER 22, 2013

In order to do this, your company needs a process to source radical ideas that can catapult your business to new heights, open up new markets, or bring in completely unfamiliar profit streams. Let’s say you’re in the energy sector. But in today’s ever-connected world, finding radical ideas seems to be getting tougher for companies.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

DECEMBER 5, 2016

Leadership would shape the conversation to ensure proposals were strategically on-point. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b Japanese pharmaceutical Eisai used them to improve care for Alzheimer’s patients. in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Strategy Driven

JANUARY 24, 2011

Execution Gap Maker #2: Nokia Nokia’s share of the worldwide market for mobile phones continued to slip in 2010. Why was this once-dominant player unable to execute and maintain its market position? So what happened? It appears Nokia was not able to coordinate decisions and activities across departments or levels of management.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

SEPTEMBER 19, 2016

This logic and the institutions that reinforce it, like competitive markets and the rule of law, have transformed the world and lifted billions of people from poverty. Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Skip Prichard

JANUARY 14, 2021

“The biggest leadership challenge is to create the future while managing the present across the entire organization.” “Consumers today are tired of marketers and being constantly marketed to. Consumers today are tired of marketers and being constantly marketed to. ” -Erich Joachimsthaler.

Brand 96

Brand Insurance Participative Open-book 96

Great Leadership By Dan

FEBRUARY 7, 2014

Rather, this sought-after executive is very ''other-directed'' and excels at harnessing the power of others through leadership and inspiration." Companies that were more likely to rely heavily on internal, rather than external, talent were those with fewer than 500 employees, energy and utility companies, and financial services firms.

Execution 283

Execution Company Press Release Survey 283

Harvard Business Review

NOVEMBER 3, 2017

When a detailed cost assessment identified significant savings potential, executive leadership boldly added another five percentage points to the target. If every activity is the result of a command from on high, the company runs the risk of sucking all the energy out of the room.

Execution 14

Execution Strategy Decentralization Short-term 14

Harvard Business Review

JUNE 30, 2014

In the words of Empson and Alvehus they have gained “legitimacy to lead through market success.” So there is something about needing to keep all 500 partners happy which brings a level of politics, which you wouldn’t get if we were an engineering company or a pharmaceuticals company.”. Consulting Leadership Leadership development'

Politics 8

Politics Pharmaceuticals Consultative Consensus 8